Dune Medical Launches US FDA Cleared Clinical Trial for Use of MarginProbe in
Breast Cancer Surgery
October 27, 2008 |  more


Dune Medical Devices is engaged in the development and commercialization of intraoperative, real-time, cancer detection devices. With platforms in development for multiple oncologic surgery applications, the company's goal is to improve the performance and outcomes of a broad range of diagnostic and therapeutic procedures, by providing a real-time assessment of the presence of cancer in tissue.

A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery
The American Journal of Surgery (2008) 196, 483-489



All contents © 2006 Dune Medical Devices. All rights reserved.
Terms of Use | Investigational use Notice